Immunocore Holdings PLC expected to post a loss of 29 pence a share - Earnings Preview

Immunocore Holdings

03/11/2023 08:32

* Immunocore Holdings PLC  IMCR.OQ   IMCR.O  is expected
to show a
rise in quarterly revenue when it reports  results 
    * The Abingdon Oxfordshire-based  company is expected to
report  a
25.8% increase in revenue to £51.845 million from £41.2 million
a year ago, according to the mean estimate from 15 analysts,
based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Immunocore Holdings
PLC
is for a loss of 29 pence per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 16 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Immunocore
Holdings PLC is $83.5​, above​ its last closing price of $46.53.
​​​

Previous quarterly performance (using preferred earnings measure
in pounds). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.31       -0.32      -0.29     Beat    9.7
 Mar. 31 2023  -0.36       -0.32      -0.35     Missed  -10.7
 Dec. 31 2022  -0.01       0.00       -0.54     Missed  -2,523
                                                        ,264.5
                                                        ​
 Sep. 30 2022  -0.22       -0.29      0.12      Beat    141.7
 ​​Jun.        -0.59       -0.67      -0.14     Beat    79.1
 30 2022                                                
 Mar. 31 2022  -0.82       -0.84      -0.37     Beat    56.2​
 Dec. 31 2021  -0.80       -0.82      -0.91     Missed  -10.9
 Sep. 30 2021  -0.75       -0.63      -0.68     Missed  -8.1
 This summary was machine generated November 3 at 08:32 GMT.  All
figures in pounds  unless otherwise stated